vTvTherapeutics' core focus is in Alzheimer's disease and Type 2 Diabetes. However, we have utilized our TTP Translational Technology® in the discovery of preclinical and clinical drug candidates against multiple molecular target classes such as kinases, GPCRs, phosphatases, proteases, and protein-protein interactions. Our programs are directed at the therapeutic areas where there are significant unmet medical needs such as CNS diseases, metabolic diseases, inflammatory diseases and cancer.